Trial intelligence / Profile preview

Bioequivalence study of cyproterone acetate 50 mg tablet vs Androcur in healthy Thai volunteers under fasting

TCTR20220830001Phase 1Completed

Sponsor
Bio-innova
Start
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of cyproterone (2 arms), sponsored by Bio-innova. Started Mar 2023; status: completed.

02

Drugs

cyproterone

Beyond the preview

Go deeper on TCTR20220830001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20220830001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call